SCHEMBL4882700

SCHEMBL4882700

CC(=O)NCc1nc(CCl)cs1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.58
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 7/20 0.49
TDP1 Q9NUW8 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPT P10636 4/20 0.48
GFER P55789 2/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.47
LMNA P02545 3/20 0.45
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 1/20 0.40
HSD17B10 Q99714 1/20 0.40
RAB9A P51151 6/20 0.38
NPC1 O15118 4/20 0.38
HTT P42858 1/20 0.38
POLB P06746 2/20 0.37
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17136360 0.80 HDAC3 (0.48) SMN1; SMN2KMT2AALDH1A1TDP1MAPT
SCHEMBL5178524 0.78 RAB9A (0.50) SMN1; SMN2KMT2AALDH1A1NPSR1MAPT
SCHEMBL9298064 0.77 FPR2 (0.50) KMT2AALDH1A1NPSR1MAPTALOX15
SCHEMBL5178520 0.77 NPSR1 (0.47) SMN1; SMN2KMT2AALDH1A1NPSR1MAPT
SCHEMBL8275731 0.77 NPC1 (0.46) SMN1; SMN2KMT2AALDH1A1NPSR1MAPT
Hydrochloric Acid SCHEMBL27651177 0.76 ALDH1A1 (0.47) SMN1; SMN2KMT2AALDH1A1TDP1MAPT
SCHEMBL13634357 0.75 L3MBTL1 (0.54) KMT2AALDH1A1NPSR1MAPTALOX15
SCHEMBL8275413 0.75 NPSR1 (0.47) SMN1; SMN2KMT2AALDH1A1NPSR1MAPT
SCHEMBL22876069 0.74 NPSR1 (0.45) KMT2AALDH1A1NPSR1MAPTALOX15
Hydrochloric Acid SCHEMBL4886963 0.74 NPSR1 (0.46) SMN1; SMN2KMT2AALDH1A1TDP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015202-A1 Thiazole Derivatives Having Vap-1 Inhibitory Activity ASTELLAS PHARMA INC. (JP) 2008-01-17 US disclosed
EP-1791835-A2 THIAZOLE DERIVATIVES HAVING VAP-1 INHIBITORY ACTIVITY Astellas Pharma Inc. (JP) 2007-06-06 EP disclosed
WO-2006028269-A2 THIAZOLE DERIVATIVES HAVING VAP-1 IHIBITORY ACTIVITY ASTELLAS PHARMA INC. (JP) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015202-A1 Thiazole Derivatives Having Vap-1 Inhibitory Activity VCAM1, VAPB, VAPA SMN1; SMN2 2277/4885KMT2A 4199/4885ALDH1A1 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.